Title
Effects of Aspirin and Low Molecular Weight Heparin in IVF Outcome.
Effects of Low Dose Aspirin and Low Molecular Weight Heparin Cotreatment, Alone and/or in Combination on Implantation and Clinical Pregnancy Rates in Repeated Implantation Failures in IVF Cycle.
Phase
Phase 3Lead Sponsor
Jeevan Jyoti HospitalStudy Type
InterventionalStatus
Unknown statusIntervention/Treatment
heparin acetylsalicylic acid enoxaparin sodium chloride ...Study Participants
400The purpose of the study is to determine whether low-dose aspirin and low molecular weight heparin improve the implantation and pregnancy rates in patients with repeated implantation failures in IVF cycle.
The investigators hypothesize that cotreatment of low dose aspirin & low molecular weight heparin may improve implantation & clinical pregnancy rates.
2500 mIU/day, subcutaneously
75 mg/day, orally
Aspirin (70 mg/day, orally) & heparin (40 mg/day, subcutaneously)
Equivalent volume of NaCl 0.9%, subcutaneously
Low molecular weight heparin, 2500 milli-International unit/day, subcutaneously
Heparin (40 mg/day, subcutaneously) and aspirin (70 mg/day, orally)
Inclusion Criteria: Aged between 19 to 35 years; Basal follicle-stimulating hormone (FSH) levels of ≤8 IU/l Body mass index (BMI) between 19 kg/m2 and 25 kg/m2 Presence of both ovaries; ≥2 previous IVF failures Good quality embryos for transfer Endometrial thickness between 10 mm and 14 mm Exclusion Criteria: Polycystic ovary syndrome Endometriosis